What Deciphera Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kelly Thomas Patrick | Chief Financial Officer | Jun 11 | Tender Offer · U | −42,478 | — | — | 0 |
| Kelly Thomas Patrick | Chief Financial Officer | Jun 11 | Disposition to Issuer · D | −72,029 | — | — | 42,478 |
| Kelly Thomas Patrick | Chief Financial Officer | Jun 11 | Grant / award · A | +34,157 | — | — | 114,507 |
| Hoerter Steven L. | President and CEO | Jun 11 | Tender Offer · U | −72,763 | — | — | 0 |
| Hoerter Steven L. | President and CEO | Jun 11 | Disposition to Issuer · D | −286,075 | — | — | 72,763 |
| Hoerter Steven L. | President and CEO | Jun 11 | Grant / award · A | +286,075 | — | — | 358,838 |
| Walsh Dennis Leo | Director | Jun 11 | Tender Offer · U | −11,000 | — | — | 0 |
| Martin Daniel C. | Chief Commercial Officer | Jun 11 | Tender Offer · U | −31,330 | — | — | 0 |
| Martin Daniel C. | Chief Commercial Officer | Jun 11 | Disposition to Issuer · D | −43,951 | — | — | 31,330 |
| Martin Daniel C. | Chief Commercial Officer | Jun 11 | Grant / award · A | +20,163 | — | — | 75,281 |
| Dhanak Dashyant | EVP & Chief Scientific Officer | Jun 11 | Disposition to Issuer · D | −184,088 | — | — | 0 |
| Dhanak Dashyant | EVP & Chief Scientific Officer | Jun 11 | Grant / award · A | +25,913 | — | — | 184,088 |
| Pitman Jama | SVP, Chief Development Officer | Jun 11 | Tender Offer · U | −34,243 | — | — | 0 |
| Pitman Jama | SVP, Chief Development Officer | Jun 11 | Disposition to Issuer · D | −53,951 | — | — | 34,243 |
| Pitman Jama | SVP, Chief Development Officer | Jun 11 | Grant / award · A | +20,163 | — | — | 88,194 |
| Friedman Franklin Stuart | Director | Jun 11 | Tender Offer · U | −10,000 | — | — | 0 |
| Sherman Matthew L | EVP & Chief Medical Officer | Jun 11 | Tender Offer · U | −72,261 | — | — | 0 |
| Sherman Matthew L | EVP & Chief Medical Officer | Jun 11 | Disposition to Issuer · D | −72,029 | — | — | 72,261 |
| Sherman Matthew L | EVP & Chief Medical Officer | Jun 11 | Grant / award · A | +34,157 | — | — | 144,290 |
| Brightstar Associates Llc | 10% owner | Apr 22 | In/At-money Exercise · X | +48,136 | $0.01 | +$481 | 23,107,844 |
Loading...
